Stock 3 Botox Botulax 100iu


  • Safe products with ISO certifications Safe products with ISO certifications
  • Fast shipping worldwide Fast shipping worldwide
  • Return policy in the event of errors on our part Return policy in the event of errors on our part

Botulax is produced in Korea by Hugel Pharma. Botulax is a safe botox with a purity of 99%, contains 100 units (U) of botulinum toxin from Clostridium type A, 0.5 milligrams of albumin (human) and 0.9 milligrams of sodium chloride. Botulax is approved in Thailand and South America and is awaiting US FDA approval. Its casing contains a freeze-dried white powder for injection which must be mixed with water for injections. The expiry date is 36 months from the production date.


It is advisable to keep botulinoin in a refrigerator with a temperature below 10 degrees.

Features of Botulax Botulium Toxin Type A:

Excellent effect

Simple procedure - Only with a few small injections

Short treatment - about 10 minutes

It takes 2 or 3 days to see an appreciable effect

Exceptional efficacy - Over 98% of users are satisfied with Botulax treatments

Effectiveness and safety demonstrated by clinical studies.

Applications / Directions

Cosmetic botox can also be used for therapeutic applications. Botulic toxin type A is useful for treating benign blepharospasm, equine foot deformity due to spasticity in patients with pediatric cerebral palsy and obviously in the aesthetic field for the temporary improvement of glabellar wrinkles.

Dosages for botox injections

For blepharospasm, the recommended initial dose is 1.25 - 2.5 U

A total dose of 4 U / kg body weight is indicated for pediatric cerebral palsy

For patients with diplegia the recommended dose is 6 U / kg of body weight divided between the two legs


For blepharospasm the effects begin to become visible after three days with a good improvement after three weeks.

For applications of pediatric cerebral palsy it is necessary to wait 3/4 weeks.

As for the aesthetic treatments of facial wrinkles the effects vary according to the dosages.


Injection site reactions may occur and even beyond where: asthenia, generalized muscle weakness, diplopia, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence and respiratory difficulties may occur. Type A botulinum should not be administered to patients with allergies to one of the ingredients present in botulax, it should also be avoided for patients with neuromuscular problems.